Walleye Capital LLC Abiomed Inc Transaction History

Walleye Capital LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$242.49 - $301.46 $274,256 - $340,951	-1,131 Reduced 47.42%	1,254 $308,000
Q2 2022 Aug 08, 2022	BUY	$224.73 - $338.64 $535,981 - $807,656	2,385 New	2,385 $590,000
Q1 2020 May 15, 2020	SELL	$130.51 - $196.01 $1.17 Million - $1.76 Million	-8,968 Closed	0 $0
Q4 2019 Feb 14, 2020	SELL	$159.31 - $223.54 $361,474 - $507,212	-2,269 Reduced 20.19%	8,968 $1.53 Million
Q3 2019 Nov 14, 2019	BUY	$175.89 - $279.23 $1.97 Million - $3.13 Million	11,217 Added 56085.0%	11,237 $2 Million
Q2 2019 Aug 14, 2019	SELL	$250.96 - $284.94 $11,795 - $13,392	-47 Reduced 70.15%	20 $5,000
Q1 2019 May 15, 2019	BUY	$276.39 - $362.25 $18,518 - $24,270	67 New	67 $19,000

137K

Ticker ABMD
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 45,460,900
Description
Abiomed, Inc. engages in the research, development, and sale of medical devices to assist or replace the pumping function of the failing heart. It also provides a continuum of care to heart failure patients. The company offers Impella 2.5, a percutaneous micro heart pump with integrated motor and sensors; and Impella CP, a device for use by inte...

Get notified when there are updates to the investment portfolio of Walleye Capital LLC, based on Form 13F filings with the SEC.

Stay updated on Walleye Capital LLC with notifications on news.